MAXIPHARMA A/S — Credit Rating and Financial Key Figures

MAXIPHARMA A/S (CVR number: 87375617) is a company from AARHUS. The company recorded a gross profit of 1824.6 kDKK in 2023. The operating profit was 538.1 kDKK, while net earnings were 226.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 19.7 %, which can be considered excellent but Return on Equity (ROE) was 6 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 72.3 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. MAXIPHARMA A/S's liquidity measured by quick ratio was 2.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.